Table 1 Baseline clinical characteristics and demographic data (n = 46).

From: Comparison of intradialytic versus home-based exercise programs on physical functioning, physical activity level, adherence, and health-related quality of life: pilot study

Variable

ID exercise

ID exercise

HB Exercise

HB exercise

Intention to treat (n = 24)

Per-protocol (n = 11)

Intention to treat (n = 22)

Per-protocol (n = 12)

Age (years)

 

   Mean (SD)

62.2 (15.0)

65.3 (15.2)

59.3 (16.1)

61.9 (12.1)

   Median (min–max)

66.5 (45.8–72.3)

69 (37–81)

57 (46–73)

65 (37–78)

Time on HD (months)

 

   Median (P25–P75)

46 (24–61)

40.6 (32.7)

45 (24–122)

89.8 (32.7)

Sex n (%)

 

   Male

15 (62.5)

15 (32.6)

14 (63.6)

14 (30.4)

   Female

9 (37.5)

9 (19.6)

8 (36.4)

8 (17.4)

Weight, (kg)

 

   Mean (SD)

73.6 (13.9)

73.6 (13.9)

70.5 (17.1)

70.5(17.1)

   Median (min–max)

71.5 (54.5–103)

71.5 (54.5–103)

67 (49–117)

67 (49–117)

Height, (cm)

 

   Mean (SD)

1.66 (0.1)

1.66 (0.1)

1.67 (0.1)

1.67 (0.1)

   Median (min–max)

1.67 (1.5–1.8)

1.67 (1.5–1.8)

1.68 (1.5–1.8)

1.68 (1.5–1.8)

Body mass index (kg/m2)

 

   Mean (SD)

26.6 (3.7)

26.6 (3.7)

25.1 (5.3)

26.6 (3.7)

   Median (min–max)

26.1 (21.3–32.9)

26.1 (21.3–32.9)

23.8 (17.6–37.8)

23.8 (17.6–37.8)

Albumin (mg/dL)

 

   Mean (SD)

3.6 (0.4)

3.6 (0.4)

3.7 (0.3)

3.7 (0.3)

   Median (min–max)

3.6 (2.5–4.2)

3.6 (2.5–4.2)

3.7 (3.3–4.2)

3.7 (3.3–4.2)

Creatinine (mg/dL)

 

   Mean (SD)

6.7 (3.4)

6.7 (3 .4)

7.9 (3.9)

7.9 (3.9)

   Median (min–max)

7.2 (3.0–12.7)

7.2 (3.0–12.7)

8.3 (3.1–17.4)

8.3 (3.1–17.4)

Hemoglobin (g/dL)

 

   Mean (SD)

10.8 (0.8)

10.8 (0.8)

10.5 (1.7)

10.5 (1.7)

   Median (min–max)

10.8 (9.4–12.5)

10.8 (9.4–12.5)

11.1 (6.6–12.8)

11.1 (6.6–12.8)

CKD Diagnosis

 

   Diabetes mellitus

3

3

5

5

   Glomerulonephritis

4

4

8

8

   Lupus

3

3

0

0

   Polycystosis

1

1

0

0

   Nephroangiosclerosis

2

2

1

1

   Pyelonephritis

1

1

1

1

   High blood pressure

3

3

0

0

   Traumatic kidney injury

0

0

2

2

   Others

7

7

5

5

Charlson comorbidity score

 

   Mean (SD)

6.6 (2.8)

6.6 (2.8)

6.0 (2.0)

6.0 (2.0)

   Median (min–max)

7 (1–12)

7 (1–12)

6 (3–10)

6 (3–10)

  1. CKD: chronic kidney disease; SD: standard deviation.
  2. Baseline data comparison between intention to treat [ID (n = 24) and HB (n = 22)] or per-protocol groups [ID (n = 11) and HB (n = 12)] with the Mann-Whitney and Chi squared test showed no significant differences.